BUDESONIDE
Budesonide is an inhaled corticosteroid reducing airway inflammation in asthma and COPD. Side effects include oral thrush, hoarseness, and mild adrenal suppression.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of action
Budesonide is a potent glucocorticoid with high topical anti‑inflammatory activity and strong glucocorticoid‑receptor affinity. After cellular uptake, it suppresses transcription of pro‑inflammatory genes, reduces cytokine release and inhibits immune‑cell recruitment. Its high first‑pass metabolism limits systemic exposure.
Benefits and advantages
Used in respiratory‑inflammation research, gastrointestinal‑inflammation modelling, corticosteroid‑receptor binding studies, aerosol‑formulation development, inflammatory‑pathway assays and comparative glucocorticoid potency testing.
Side effects and risks
Risks include adrenal suppression, oral candidiasis (in inhaled use), dysphonia, systemic glucocorticoid effects at high doses and local irritation. Handle using steroid‑active compound precautions.
Datasheet
| Molecular Formula | C25H34O6 |
|---|---|
| Molecular Weight | 430.5 g/mol |
| CAS Number | 51333-22-3 |
| Storage Condition | Conditions for safe storage, including any incompatibilities: Keep container tightly closed in a dry and well-ventilated place. |
| Solubility | Practically insoluble in water |
| Purity | Purity information is available upon request (COA). |
| Synonym | budesonide; Pulmicort; 51333-22-3; Rhinocort; Entocort |
| IUPAC/Chemical Name | (1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one |
| InChl Key | VOVIALXJUBGFJZ-KWVAZRHASA-N |
| InChl Code | InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.


